• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [42 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2024 NIHR Health Technology Assessment programme Strategies used for childhood chronic functional constipation: the SUCCESS evidence synthesis
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Anorectal biofeedback therapy in primary constipation]
2022 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Efficacy and safety of transanal irrigation in adults with bowel dysfunction]
2020 Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: pharmacological treatment for fecal elimination in a person receiving palliative care or presenting a geriatric profile]
2020 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Naldemedine (opioid-induced constipation) - Benefit assessment according to §35a Social Code Book V]
2020 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Naldemedine (opioid-induced constipation) - Addendum to Commission A20-45]
2020 National Institute for Health and Care Excellence (NICE) Naldemedine for treating opioid-induced constipation. NICE technology appraisal guidance 651
2018 National Institute for Health and Care Excellence (NICE) Peristeen Plus transanal irrigation system for managing bowel dysfunction. NICE medical technologies guidance 36
2017 National Institute for Health and Care Excellence (NICE) Methylnaltrexone bromide for treating opioid-induced constipation (terminated appraisal). NICE technology appraisal guidance 468
2016 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Prucalopride (Resolor®)
2016 NIHR Horizon Scanning Centre (NIHR HSC) Naldemedine for opioid-induced constipation in adults
2015 NIHR Health Technology Assessment programme Interventions for preventing postpartum constipation
2015 NIHR Health Technology Assessment programme Naloxegol for treating opioid-induced constipation
2015 National Institute for Health and Care Excellence (NICE) Naloxegol for treating opioid-induced constipation. NICE technology appraisal guidance 345
2014 NIHR Health Technology Assessment programme Lubiprostone for chronic idiopathic constipation [ID725]
2014 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Linaclotide (Constella®)
2014 Penn Medicine Center for Evidence-based Practice (CEP) Docusate for treatment of constipation
2014 NIHR Horizon Scanning Centre (NIHR HSC) Prucalopride (Resolor) for adult males with chronic constipation – third line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Methylnaltrexone bromide (Relistor) for opioid-induced constipation in adult patients with chronic non-malignant pain
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Linaclotide
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for constipation: a review of systematic reviews
2013 NIHR Horizon Scanning Centre (NIHR HSC) Methylnaltrexone bromide (Relistor) for opioid-induced constipation
2013 Agency for Healthcare Research and Quality (AHRQ) Wireless motility capsule versus other diagnostic technologies for evaluating gastroparesis and constipation: a comparative effectiveness review
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Linaclotide - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 National Institute for Health and Care Excellence (NICE) Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal). NICE technology appraisal guidance 277
2012 NIHR Horizon Scanning Centre (NIHR HSC) Naloxegol (NKTR-118) for opioid-induced constipation
2012 NIHR Horizon Scanning Centre (NIHR HSC) Lubiprostone (Amitiza) for opioid-induced constipation in patients with chronic non-cancer pain
2012 Blue Cross Blue Shield Association (BCBS) Wireless motility capsule in the diagnosis and evaluation of gastroparesis or slow-transit constipation
2011 NIHR Health Technology Assessment programme Prucalopride for the treatment of chronic constipation in women in whom laxatives fail to provide adequate relief
2010 NIHR Health Technology Assessment programme LIFELAX - diet and LIFEstyle versus LAXatives in the management of chronic constipation in older people: randomised controlled trial
2010 National Institute for Health and Care Excellence (NICE) Stapled transanal rectal resection for obstructed defaecation syndrome. NICE interventional procedures guidance 351
2010 National Institute for Health and Care Excellence (NICE) Prucalopride for the treatment of chronic constipation in women. NICE technology appraisal guidance 211
2009 Norwegian Knowledge Centre for the Health Services (NOKC) [Methylnaltrexone for opioid-induced constipation in cancer treatment]
2008 NIHR Health Technology Assessment programme STOOL - Stepped Treatment of Older adults On Laxatives - Primary Research
2008 NIHR Horizon Scanning Centre (NIHR HSC) Methylnaltrexone (MOA-728) for postoperative ileus
2007 Canadian Agency for Drugs and Technologies in Health (CADTH) Lubiprostone
2007 NIHR Horizon Scanning Centre (NIHR HSC) Methylnatrexone for opioid induced constipation in advanced illness and palliative care: horizon scanning technology briefing
2006 NIHR Horizon Scanning Centre (NIHR HSC) Alvimopan (Entrareg) for opioid-induced bowel dysfunction
2001 University of York Effectiveness of laxatives in adults
1998 ECRI Biofeedback for the treatment of constipation in children
1997 NIHR Health Technology Assessment programme Systematic review of the effectiveness of laxatives in the elderly
1997 Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Treatment of constipation in children with biofeedback-training - primary research